相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predicting Lung Deposition of Extrafine Inhaled Corticosteroid-Containing Fixed Combinations in Patients with Chronic Obstructive Pulmonary Disease Using Functional Respiratory Imaging: AnIn SilicoStudy
Omar S. Usmani et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2021)
Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD
Ting-Yu Chang et al.
CHEST (2020)
Risk of Pneumonia with Different Inhaled Corticosteroids in COPD Patients: A Meta-Analysis
Qian Zhang et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review
Paolo Solidoro et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2019)
Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD
Luigino Calzetta et al.
CHEST (2019)
What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape
Federico Lavorini et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Harmonizing the Nomenclature for Therapeutic Aerosol Particle Size: A Proposal
Elizabeth V. Hillyer et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2018)
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
Alberto Papi et al.
LANCET (2018)
Current appraisal of single inhaler triple therapy in COPD
Brian Lipworth et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study
Christer Janson et al.
RESPIRATORY RESEARCH (2018)
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
Jorgen Vestbo et al.
LANCET (2017)
Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study
Jaymin B. Morjaria et al.
LUNG (2017)
The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study
Rupert Jones et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids
Samatha Sonnappa et al.
PLOS ONE (2017)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report
Claus F. Vogelmeier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Multivariate and Propensity Score Matching Software with Automated Balance Optimization: TheMatchingPackage forR
Jasjeet S. Sekhon
Journal of Statistical Software (2015)
Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD
Courtney Crim et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations
J. A. Wedzicha et al.
RESPIRATORY MEDICINE (2014)
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
Dirkje S. Postma et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2014)
Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis
Yuji Oba et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2014)
Inhaled corticosteroids in COPD and the risk of serious pneumonia
Samy Suissa et al.
THORAX (2013)
Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)
Christer Janson et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study
Mette Thomsen et al.
LANCET RESPIRATORY MEDICINE (2013)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD Patients
Wilfried De Backer et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2010)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma
H. Derendorf et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Comparative Pharmacology, Bioavailability, Pharmacokinetics, and Pharmacodynamics of Inhaled Glucocorticosteroids
Melanie Huebner et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2005)
分享论文
